PYC 2.50% 20.5¢ pyc therapeutics limited

Ann: PMS Drug Candidate Effective In Human Brain Cells, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 107 Posts.
    lightbulb Created with Sketch. 100
    I think it’s because we are treating the protein deficit which is the root cause potentially a very effective treatment rather than the inflammation which is a result of the disease process like NEU drug. They have different mechanisms of action. I think PYC probably believe it is better to treat the root cause. But combination therapies are common in medicine and as they work on two different mechanisms of action it is possible they will work together better than alone if either is not completely effective.
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.